Abbott Laboratories (BMV:ABT)

Market Cap	3.32T -24.3%
Revenue (ttm)	798.05B +5.7%
Net Income	117.45B -51.3%
EPS	66.97 -51.3%
Shares Out	n/a
PE Ratio	28.26
Forward PE	19.39
Dividend	45.08 (2.37%)
Ex-Dividend Date	Jan 15, 2026

Volume	385
Average Volume	847
Open	1,928.00
Previous Close	1,900.00
Day's Range	1,927.90 - 1,938.00
52-Week Range	1,818.98 - 2,915.60
Beta	0.75
RSI	32.51
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 115,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD